Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$361M |
| 2 |
CVS Health
CVS
|
+$180M |
| 3 |
Cigna
CI
|
+$158M |
| 4 |
Microsoft
MSFT
|
+$102M |
| 5 |
Amazon
AMZN
|
+$90M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$301M |
| 2 |
AET
Aetna Inc
AET
|
+$270M |
| 3 |
PX
Praxair Inc
PX
|
+$184M |
| 4 |
ANDV
Andeavor
ANDV
|
+$97.3M |
| 5 |
COL
Rockwell Collins
COL
|
+$89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.86% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 10.39% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Turkcell
TKC
$4.68B
| $2.94M | ﹤0.01% |
+522,812
| New | +$2.78M |
|
2177
Par Pacific Holdings
PARR
$4.31B
| $2.93M | ﹤0.01% |
206,752
-21,202
| -9% | -$361K |
|
2178
Pathward Financial
CASH
$1.86B
| $2.92M | ﹤0.01% |
150,840
-1,824
| -1% | -$42.6K |
|
2179
Peoples Bancorp
PEBO
$1.5B
| $2.91M | ﹤0.01% |
96,662
-753
| -0.8% | -$25.1K |
|
|
ITCI
2180
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.91M | ﹤0.01% |
255,051
-3,244
| -1% | -$52.4K |
|
2181
Manitowoc
MTW
$497M
| $2.88M | ﹤0.01% |
194,914
-519
| -0.3% | -$9.69K |
|
2182
CareDx
CDNA
$2.26B
| $2.86M | ﹤0.01% |
113,646
+21,124
| +23% | +$543K |
|
2183
Liberty Energy
LBRT
$3.05B
| $2.85M | ﹤0.01% |
220,314
-42,105
| -16% | -$764K |
|
|
GNC
2184
DELISTED
GNC Holdings, Inc.
GNC
| $2.85M | ﹤0.01% |
1,203,933
+45,314
| +4% | +$152K |
|
|
DCOM
2185
DELISTED
Dime Community Bancshares
DCOM
| $2.85M | ﹤0.01% |
167,946
-8,457
| -5% | -$144K |
|
2186
Collegium Pharmaceutical
COLL
$1.15B
| $2.84M | ﹤0.01% |
165,408
-41,455
| -20% | -$709K |
|
|
VEDL
2187
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $2.83M | ﹤0.01% |
+245,440
| New | +$2.8M |
|
|
EGL
2188
DELISTED
Engility Holdings, Inc.
EGL
| $2.83M | ﹤0.01% |
99,281
+143
| +0.1% | +$4.45K |
|
2189
Titan International
TWI
$466M
| $2.82M | ﹤0.01% |
604,805
+38,294
| +7% | +$248K |
|
2190
Ennis
EBF
$552M
| $2.82M | ﹤0.01% |
146,384
+2,572
| +2% | +$49.4K |
|
2191
Champion Homes
SKY
$4.37B
| $2.82M | ﹤0.01% |
191,710
+106,627
| +125% | +$2.36M |
|
2192
Rhythm Pharmaceuticals
RYTM
$6.81B
| $2.81M | ﹤0.01% |
104,522
-1,271
| -1% | -$35.1K |
|
2193
Inspire Medical Systems
INSP
$1.45B
| $2.81M | ﹤0.01% |
66,428
+22,789
| +52% | +$969K |
|
|
COOP
2194
DELISTED
Mr. Cooper
COOP
| $2.81M | ﹤0.01% |
240,372
+92,218
| +62% | +$1.32M |
|
|
AGS
2195
DELISTED
PlayAGS
AGS
| $2.81M | ﹤0.01% |
121,919
-3,147
| -3% | -$74.7K |
|
|
BSTC
2196
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $2.8M | ﹤0.01% |
46,244
| – | – |
|
2197
Omeros
OMER
$857M
| $2.8M | ﹤0.01% |
251,490
-779
| -0.3% | -$10.9K |
|
2198
Central Garden & Pet Co
CENT
$2.69B
| $2.8M | ﹤0.01% |
101,588
-5,442
| -5% | -$143K |
|
|
ONIT
2199
Onity Group
ONIT
$309M
| $2.8M | ﹤0.01% |
139,139
+16,825
| +14% | +$692K |
|
|
MODN
2200
DELISTED
MODEL N, INC.
MODN
| $2.79M | ﹤0.01% |
211,218
-94,593
| -31% | -$1.37M |
|
Similar funds
Charles Schwab's Q4 2018 Portfolio in Review
As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
- Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
- Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
- Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
- Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
- Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
- Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.
Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.